YK Bioventures

Judo Bio develops oligonucleotide medicines, including ligand-siRNA conjugate drugs, delivered to the kidney for systemic and renal diseases using its STRIKE (Selectively Targeting RNA Into KidnEy) platform.

BiotechHealthtechCambridge, US

Andrew Fraley(Co-founder)OMMER CHOHAN(Executive Officer)JAMES JEFFREY GOATER(Executive Officer, Director)CHELSEA PLACE JOHNSON(Director)Simon Read(CEO)Alfica Sehgal

Co-investorsAtlas VentureDigitalis VenturesThe Column GroupDroia Ventures

Neurona is a clinical-stage biotherapeutics company developing allogeneic, off-the-shelf regenerative neural cell therapies that integrate into neural circuits to treat chronic neurological disorders.

BiotechHealthtechSouth San Francisco, US

Cory Nicholas(Executive Officer, Director, Promoter)James Stutz(Executive Officer)Arnold Kriegstein(Director)

BoardPeter Svennilson(Director)inTim Kutzkey(Director)Ray Kelleher(Director)

Co-investorsBerkeley FrontierIaso VenturesThe Column GroupYsios CapitalAlexandriaFidelity Investments+7 more

Normunity develops biologic anti-cancer therapies that act at the interface of the immune system and tumors, targeting mechanisms tumors use to evade immune surveillance.

BiotechHealthtech

Rachel Humphrey(Founding Chief Executive Officer)Lieping Chen(Scientific Founder)Mitchell Keegan(Chief Development Officer)William LaRochelle(Chief Scientific Officer)Stacy M. Plum(Chief Technology Officer)

Co-investorsSanofi VenturesTaiho Ventures, LLCPfizer VenturesSamsara BioCapitalCanaan PartnersConnecticut Innovations+3 more

Pelage develops regenerative medicines for hair loss based on stem cell biology, with a lead candidate (PP405) that is a topical small-molecule drug designed to reactivate dormant hair follicle stem cells.

BiotechHealthtechLongevity

William Lowry(PhD)Christina Weng(Chief Medical Officer)Nathan Wheeler(Chief Operating Officer)Daniel Gil(PhD)

Co-investorsGV (Google Ventures)ARCH Venture PartnersHAWKTAILVisionary Ventures

BiotechLos Angeles, US

William Edward Lowry(Director)Daniel Gil(Executive Officer, Director)Heather Christofk(Executive Officer)

BoardCathy Friedman(Director)

Co-investorsARCH Venture PartnersGV (Google Ventures)Visionary Ventures

Protego provides chargeback management software that automates dispute processes and tracks chargebacks in real time to help merchants identify patterns in fraudulent activity and recover revenue.

CybersecurityEnterprise SoftwareSaaSBogotá, CO

Pablo Rojas(Founder)in

Co-investorsNovartis Venture FundY CombinatorForbionGlilot Capital PartnersOmega Funds

Protego Bio is a biotech company developing first-in-class therapies for protein misfolding diseases, including its lead candidate PROT-001 for AL amyloidosis, based on research into pharmacological chaperones.

AI & Machine LearningBiotechDeep TechDigital HealthSan Diego, US

Co-investorsDroia VenturesNovartis Venture FundDigitalis VenturesForbionLightspeed Venture PartnersMPM BioImpact+1 more

Vivere is a data-driven incubator that creates consumer goods brands and products, having launched over 12 brands and 300 products in the fast-moving consumer goods (FMCG) industry.

ConsumerDirect to ConsumerE-commerceHamburg, DE

Co-investorsArmada Investment AGRockaway VenturesBerkeley FrontierPillarredalpine